maria ilaria del principe

UNIVERSITY TOR VERGATA

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Collaborators (10)

Roland B. Walter

University of Washington

UNITED STATES

Francesca Farina

IRCCS San Raffaele Scientific Institute

GUGLIELMO MANENTI

PROFESSORE ASSOCIATO

University of Rome Tor Vergata

Mario Delia

University of Bari Aldo Moro

Massimiliano BONIFACIO

University of Verona

Fabio Guolo

University of Genova

Livio PAGANO

Prof associato di Ematologia

Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia

Francesco Buccisano

Associate Professor

UNIVERSITY TOR VERGATA

Patrizia Chiusolo

Daniele Zama

University of Bologna

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

maria ilaria del principe

Research Interests

Explore related searches

Contact this professor

Articles (18)

Collaborators (10)

Roland B. Walter

Francesca Farina

GUGLIELMO MANENTI

Mario Delia

Massimiliano BONIFACIO

Fabio Guolo

Livio PAGANO

Francesco Buccisano

Patrizia Chiusolo

Daniele Zama

Make your next move.

maria ilaria del principe

Research Interests

Explore related searches

Contact this professor

Articles (18)

Association of [<sup>18</sup>F]-FDG PET/CT-Derived Radiomic Features with Clinical Outcomes and Genomic Profiles in Patients with Chronic Lymphocytic Leukemia

Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of Response

Acute Leukemia and Latent Tuberculosis Infection in Italy: Quantiferon-Tb Test Screening in a Low Tuberculosis Incidence Country

Antiviral prophylaxis to prevent herpes simplex virus (HSV) and varicella zoster virus (VZV) reactivation in adult patients with newly diagnosed acute leukemia: results of a survey submitted to Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group

CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience

Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022

Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort

Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group

Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in “Real-Life”: The SEIFEM Experience

Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study

High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study

When Viruses Meet Fungi: Tackling the Enemies in Hematology

Time for Dynamic Assessment of Fitness in Acute Myeloid Leukemia

Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World Experience

In <i>BCR-ABL1</i> Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces Hypofibrinogenemia

Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia

Collaborators (10)

Roland B. Walter

Francesca Farina

GUGLIELMO MANENTI

Mario Delia

Massimiliano BONIFACIO

Fabio Guolo

Livio PAGANO

Francesco Buccisano

Patrizia Chiusolo

Daniele Zama

Make your next move.